Irdianto S, Dwiranti A, Bowolaksono A
Hum Cell. 2025; 38(2):58.
PMID: 39969664
DOI: 10.1007/s13577-025-01178-y.
Wu M, Guan G, Yin H, Niu Q
Viruses. 2024; 16(7).
PMID: 39066258
PMC: 11281655.
DOI: 10.3390/v16071096.
Wu T, Hou H, Dey A, Bachu M, Chen X, Wisniewski J
iScience. 2024; 27(7):109797.
PMID: 38993671
PMC: 11237862.
DOI: 10.1016/j.isci.2024.109797.
Zhang Y, Fong K, Mao F, Wang R, Allison D, Napier D
Cell Rep. 2024; 43(7):114431.
PMID: 38968071
PMC: 11334074.
DOI: 10.1016/j.celrep.2024.114431.
Schep R, Trauernicht M, Vergara X, Friskes A, Morris B, Gregoricchio S
Nucleic Acids Res. 2024; 52(15):8815-8832.
PMID: 38953163
PMC: 11347147.
DOI: 10.1093/nar/gkae570.
Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review).
Yongprayoon V, Wattanakul N, Khomate W, Apithanangsiri N, Kasitipradit T, Nantajit D
Oncol Rep. 2024; 51(6).
PMID: 38606512
PMC: 11040537.
DOI: 10.3892/or.2024.8733.
BRD2 promotes antibody class switch recombination by facilitating DNA repair in collaboration with NIPBL.
Gothwal S, Refaat A, Nakata M, Stanlie A, Honjo T, Begum N
Nucleic Acids Res. 2024; 52(8):4422-4439.
PMID: 38567724
PMC: 11077081.
DOI: 10.1093/nar/gkae204.
ARGLU1 enhances promoter-proximal pausing of RNA polymerase II and stimulates DNA damage repair.
Bachus S, Akkerman N, Fulham L, Graves D, Helwer R, Rempel J
Nucleic Acids Res. 2024; 52(10):5658-5675.
PMID: 38520408
PMC: 11162773.
DOI: 10.1093/nar/gkae208.
αKG-mediated carnitine synthesis promotes homologous recombination via histone acetylation.
Uboveja A, Huang Z, Buj R, Amalric A, Wang H, Tangudu N
bioRxiv. 2024; .
PMID: 38370789
PMC: 10871207.
DOI: 10.1101/2024.02.06.578742.
IκB kinase-α coordinates BRD4 and JAK/STAT signaling to subvert DNA damage-based anticancer therapy.
Pecharroman I, Sole L, Alvarez-Villanueva D, Lobo-Jarne T, Alonso-Maranon J, Bertran J
EMBO J. 2023; 42(21):e114719.
PMID: 37737566
PMC: 10620764.
DOI: 10.15252/embj.2023114719.
A new vulnerability to BET inhibition due to enhanced autophagy in BRCA2 deficient pancreatic cancer.
Lee E, Archasappawat S, Ji K, Pena J, Fernandez-Vega V, Gangaraju R
Cell Death Dis. 2023; 14(9):620.
PMID: 37735513
PMC: 10514057.
DOI: 10.1038/s41419-023-06145-9.
Regulation of Notch1 Signalling by Long Non-Coding RNAs in Cancers and Other Health Disorders.
Kalafut J, Czerwonka A, Czapla K, Przybyszewska-Podstawka A, Hermanowicz J, Rivero-Muller A
Int J Mol Sci. 2023; 24(16).
PMID: 37628760
PMC: 10454443.
DOI: 10.3390/ijms241612579.
Crystal structure of [1,2,4]triazolo[4,3-b]pyridazine derivatives as BRD4 bromodomain inhibitors and structure-activity relationship study.
Kim J, Pandit N, Yoo M, Park T, Choi J, Park C
Sci Rep. 2023; 13(1):10805.
PMID: 37402749
PMC: 10319850.
DOI: 10.1038/s41598-023-37527-w.
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
Yang J, Xu J, Wang W, Zhang B, Yu X, Shi S
Signal Transduct Target Ther. 2023; 8(1):210.
PMID: 37217462
PMC: 10203321.
DOI: 10.1038/s41392-023-01480-x.
Kinome-wide screening uncovers a role for Bromodomain Protein 3 in DNA double-stranded break repair.
Wang C, Chan D, Hendrickson E
DNA Repair (Amst). 2023; 122:103445.
PMID: 36608404
PMC: 10353298.
DOI: 10.1016/j.dnarep.2022.103445.
Arginine methylation of BRD4 by PRMT2/4 governs transcription and DNA repair.
Liu L, Lin B, Yin S, Ball L, Delaney J, Long D
Sci Adv. 2022; 8(49):eadd8928.
PMID: 36475791
PMC: 9728970.
DOI: 10.1126/sciadv.add8928.
Covalent Modification of Bromodomain Proteins by Peptides Containing a DNA Damage-Induced, Histone Post-Translational Modification.
Jacinto M, Heidenreich D, Muller S, Greenberg M
Chembiochem. 2022; 23(22):e202200373.
PMID: 36173930
PMC: 9675715.
DOI: 10.1002/cbic.202200373.